-
-
-
-
-
-
-
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025
-
-
-
-
-
-
-
Quanterix appoints two new directors and executive chair
-
-
-
-
-
-
-
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
-
-
-
-
-
-
-
Illumina (ILMN) addresses recent developments in China, updates guidance
-
-
-
-
-
-
-
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications
-
-
-
-
-
-
-
Illumina announces strategy to accelerate value creation
-
-
-
-
-
-
-
Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations
-
1,168,811 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

